>

Astrazeneca PLC Performance

<div class='circular--portrait' style='background:#0D8ECF;color: white;font-size:4em;padding-top: 25px;;'>AS</div>
AZN -- USA Stock  

Fiscal Quarter End: March 31, 2020  

The firm shows Beta (market volatility) of 0.0 which signifies that the returns on MARKET and Astrazeneca PLC are completely uncorrelated. Although it is extremely important to respect Astrazeneca PLC historical returns, it is better to be realistic regarding the information on equity current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Astrazeneca PLC technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Astrazeneca PLC right now shows a risk of 0.0%. Please confirm Astrazeneca PLC Value At Risk as well as the relationship between Skewness and Day Median Price to decide if Astrazeneca PLC will be following its price patterns.
00

Risk-Adjusted Performance

Over the last 30 days Astrazeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Allthough quite persistent forward indicators, Astrazeneca PLC is not utilizing all of its potentials. The current stock price mess, may contribute to short term losses for the partners.
Quick Ratio0.68
Fifty Two Week Low36.83
Target High Price57.00
Payout Ratio271.84%
Fifty Two Week High51.55
Target Low Price48.50
Trailing Annual Dividend Yield5.72%

Astrazeneca PLC Relative Risk vs. Return Landscape

If you would invest  5,017  in Astrazeneca PLC on January 25, 2020 and sell it today you would earn a total of  0.00  from holding Astrazeneca PLC or generate 0.0% return on investment over 30 days. Astrazeneca PLC is generating negative expected returns assuming volatility of 0.0% on return distribution over 30 days investment horizon. In other words, 0% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
    
  Risk (%) 

Astrazeneca PLC Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
AZN
Based on monthly moving average Astrazeneca PLC is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Astrazeneca PLC by adding it to a well-diversified portfolio.

Astrazeneca PLC Alerts

Equity Alerts and Improvement Suggestions

Astrazeneca PLC is not yet fully synchronised with the market data
Astrazeneca PLC has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company has 20.31 B in debt with debt to equity (D/E) ratio of 148.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Astrazeneca PLC has Current Ratio of 0.9 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
Please continue to Trending Equities. Please also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Company logos by clearbit